| HOME >> BIOLOGY >> TECHNOLOGY |
CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/ -- University Hospitals Case Medical Center and Cardialysis BV today announced that the Companies have the intention to found Cardialysis Cleveland to provide combined clinical drug development and medical imaging services to clients that are developing therapeutics or medical devices for cardiovascular indications in world wide studies.
University Hospitals Case Medical Center is the primary hospital of Case Western Reserve University (CWRU) School of Medicine, a premier biomedical research institution in the United States. University Hospitals Heart & Vascular Institute is dedicated to breakthrough medical advancements and practices to deliver superior cardiac and vascular clinical outcomes. A world renowned team of physician investigators has been assembled to capitalize on the basic science and biotechnology tradition of CWRU. The Cardiovascular Imaging Core Lab is leading the development of novel imaging technologies, such as OCT (optical coherence tomography) and cardiac MRI, and applied methodologies for clinical trials.
Cardialysis is a full service Academic Contract Research Organization and a leading provider of imaging core laboratory and clinical event adjudication services for studies in cardiac device and other cardiovascular indications. Cardialysis provides centralized expert evaluations of medical images from multi-modality environments including angiography, IVUS (intra vascular ultrasound) and IVUS related techniques (such as virtual histology and palpography), OCT, MRI, MSCT (multi slice computer tomography), ECHO and PV-loop.
The collaboration will focus on founding Cardialysis-Cleveland, a core
lab with globally standardized Code Federal Regulations chapter 21 part 11
compliant technologies enabling global large-scale trials and registries in
the coronary and peripheral vascular devices as well as in drug trials. The
combined expertise of the comp
'/>"/>
| SOURCE Cardialysis BV Copyright©2008 PR Newswire. All rights reserved |